Aclaris raises $20M in private placement

Aclaris Therapeutics Inc. (NASDAQ:ACRS) raised $20 million through the sale of 1.1 million shares at $18.50 in a

Read the full 183 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE